Polycystic kidney disease interventions: Difference between revisions
Jump to navigation
Jump to search
m Khurram Afzal moved page Polycystic kidney disease genetic testing to Polycystic kidney disease intervention |
m Bot: Removing from Primary care |
||
| (7 intermediate revisions by one other user not shown) | |||
| Line 1: | Line 1: | ||
__NOTOC__ | |||
{{Polycystic kidney disease}} | {{Polycystic kidney disease}} | ||
{{CMG}}; {{AE}} | {{CMG}}; {{AE}} {{MKA}} | ||
==Overview== | ==Overview== | ||
[[Dialysis]] is not the first-line treatment option for patients with polycystic kidney disease. [[Dialysis]] is usually reserved for patients with either [[End stage renal disease|end stage renal disease (ESRD)]] or [[renal failure]]. | |||
== | ==Indications== | ||
[[Dialysis]] is not the first-line treatment option for patients with polycystic kidney disease. [[Dialysis]] is usually reserved for patients with either:<ref name="pmid18832246">{{cite journal |vauthors=Grantham JJ |title=Clinical practice. Autosomal dominant polycystic kidney disease |journal=N. Engl. J. Med. |volume=359 |issue=14 |pages=1477–85 |date=October 2008 |pmid=18832246 |doi=10.1056/NEJMcp0804458 |url=}}</ref> | |||
*[[End stage renal disease|End stage renal disease (ESRD)]] | |||
*[[Renal failure]] | |||
==Dialysis== | |||
*[[Dialysis]] is the mainstay of treatment for [[ESRD]] and [[renal failure]] in patients with polycystic kidney disease<ref name="pmid9044324">{{cite journal |vauthors=Pirson Y, Christophe JL, Goffin E |title=Outcome of renal replacement therapy in autosomal dominant polycystic kidney disease |journal=Nephrol. Dial. Transplant. |volume=11 Suppl 6 |issue= |pages=24–8 |date=1996 |pmid=9044324 |doi= |url=}}</ref> | |||
*[[Peritoneal dialysis]] may have a survival benefit over [[hemodialysis]]<ref name="pmid11924752">{{cite journal |vauthors=Abbott KC, Agodoa LY |title=Polycystic kidney disease at end-stage renal disease in the United States: patient characteristics and survival |journal=Clin. Nephrol. |volume=57 |issue=3 |pages=208–14 |date=March 2002 |pmid=11924752 |doi= |url=}}</ref> | |||
*[[Hemodialysis]] is the preferred modality for [[Renal replacement therapy|renal replacement]] in patients with polycystic kidney disease<ref name="pmid9044324">{{cite journal |vauthors=Pirson Y, Christophe JL, Goffin E |title=Outcome of renal replacement therapy in autosomal dominant polycystic kidney disease |journal=Nephrol. Dial. Transplant. |volume=11 Suppl 6 |issue= |pages=24–8 |date=1996 |pmid=9044324 |doi= |url=}}</ref> | |||
==Contraindications== | |||
*[[Peritoneal dialysis]] is not preferred in patients with [[PKD]], because of the lack of ability to acoomodate large volume of [[peritoneal]] [[fluid]]<ref name="pmid10695753">{{cite journal |vauthors=Lederman ED, McCoy G, Conti DJ, Lee EC |title=Diverticulitis and polycystic kidney disease |journal=Am Surg |volume=66 |issue=2 |pages=200–3 |date=February 2000 |pmid=10695753 |doi= |url=}}</ref> | |||
*[[Peritoneal dialysis]] is also avoided in patients with [[aortic]] [[aneurysms]] | |||
*[[Anticoagulants]] required for [[hemodialysis]] should be used with caution due to pre existing [[hematuria]] | |||
==References== | ==References== | ||
{{ | {{Reflist|2}} | ||
{{WH}} | {{WH}} | ||
{{WS}} | {{WS}} | ||
[[Category:Up-To-Date]] | |||
[[Category:Medicine]] | |||
[[Category:Nephrology]] | |||
Latest revision as of 23:46, 29 July 2020
|
Polycystic kidney disease Microchapters |
|
Differentiating Polycystic kidney disease from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Polycystic kidney disease interventions On the Web |
|
American Roentgen Ray Society Images of Polycystic kidney disease interventions |
|
Risk calculators and risk factors for Polycystic kidney disease interventions |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: M. Khurram Afzal, MD [2]
Overview
Dialysis is not the first-line treatment option for patients with polycystic kidney disease. Dialysis is usually reserved for patients with either end stage renal disease (ESRD) or renal failure.
Indications
Dialysis is not the first-line treatment option for patients with polycystic kidney disease. Dialysis is usually reserved for patients with either:[1]
Dialysis
- Dialysis is the mainstay of treatment for ESRD and renal failure in patients with polycystic kidney disease[2]
- Peritoneal dialysis may have a survival benefit over hemodialysis[3]
- Hemodialysis is the preferred modality for renal replacement in patients with polycystic kidney disease[2]
Contraindications
- Peritoneal dialysis is not preferred in patients with PKD, because of the lack of ability to acoomodate large volume of peritoneal fluid[4]
- Peritoneal dialysis is also avoided in patients with aortic aneurysms
- Anticoagulants required for hemodialysis should be used with caution due to pre existing hematuria
References
- ↑ Grantham JJ (October 2008). "Clinical practice. Autosomal dominant polycystic kidney disease". N. Engl. J. Med. 359 (14): 1477–85. doi:10.1056/NEJMcp0804458. PMID 18832246.
- ↑ 2.0 2.1 Pirson Y, Christophe JL, Goffin E (1996). "Outcome of renal replacement therapy in autosomal dominant polycystic kidney disease". Nephrol. Dial. Transplant. 11 Suppl 6: 24–8. PMID 9044324.
- ↑ Abbott KC, Agodoa LY (March 2002). "Polycystic kidney disease at end-stage renal disease in the United States: patient characteristics and survival". Clin. Nephrol. 57 (3): 208–14. PMID 11924752.
- ↑ Lederman ED, McCoy G, Conti DJ, Lee EC (February 2000). "Diverticulitis and polycystic kidney disease". Am Surg. 66 (2): 200–3. PMID 10695753.